SIK-KEE AU TCM BRAIN THEORY
LIVE

Serial Number

97150897

Owner

REGENCELL BIOSCIENCE LIMITED

Attorney

Todd A. Denys

Filing Date

Dec 1, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SIK-KEE AU TCM BRAIN THEORY Trademark

Serial Number: 97150897 • Registration: 7349974

SIK-KEE AU TCM BRAIN THEORY is a trademark filed by REGENCELL BIOSCIENCE LIMITED on December 1, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

REGENCELL BIOSCIENCE LIMITED (3 trademarks)

11/F, First Commercial Building
Causeway Bay , HK

Entity Type: 16

Trademark Details

Filing Date

December 1, 2021

Registration Date

April 9, 2024

Published for Opposition

January 23, 2024

Goods & Services

Medical services; medical diagnostic services; providing information in the field of medical diagnostics; medical services, namely, assessment of disease risk factors; providing information relating to diagnosis and monitoring of chronic diseases, conditions and functional disorders; hospital services; medical clinic services; medical aid services; medical assistance; pharmaceutical advice; preparation of prescriptions by pharmacists; health consultation; medical consultation; pharmacist dispensing service; nutritional therapy services; medical care; health care; health center services; health counseling; provision of information relating to medical images for the purpose of detecting, monitoring and treating human diseases; all the aforesaid services are not related to the treatment or prevention of the diseases or conditions relating to retinal ganglion cells or radial glia cells; hygienic and beauty care for human beings; medical services for the diagnosis of diseases, disorders and degenerative conditions associated with aging; physiotherapy; diet nutrition guidance

Pharmaceutical research and development services; research and development services in the fields of chronic diseases, conditions and functional disorders; research and development services in the fields of pharmaceuticals; medical and scientific research in the nature of conducting clinical trials for others; medical laboratory services; medical and scientific research in the nature of evaluating drug effectiveness through conducting clinical trials for others; medical research; provision of biological and scientific research information, advice and consultancy in relation to health and medical disorders; all the aforesaid services are not related to the treatment or prevention of the diseases or conditions relating to retinal ganglion cells or radial glia cells; scientific research and development services; chemical research and analysis; research and development services in the field of diseases, disorders, and degenerative conditions associated with aging; research and development services in the fields of biotechnology; scientific laboratory services; product quality testing; biological research and analysis; technical research in the field of herbal medicines; research and development of new products for others; scientific research

Filing History

REGISTERED-PRINCIPAL REGISTER
Apr 9, 2024 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 9, 2024 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 3, 2024 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Dec 18, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 15, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 10, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 17, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 20, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 20, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 20, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2021 NWOS
NEW APPLICATION ENTERED
Dec 4, 2021 NWAP